Advisory board
Our Advisory Board for 2012 includes:
- Rakesh Dixit, VP R&D, Global Head, Biologics Safety Assessment, Pathology & LAR, MedImmune
- Mike Buckley, VP Process Sciences, Takeda
- Alex Lugovskoy, Director of Therapeutic Design, Merrimack Pharmaceuticals
- Paolo Martini, Director Molecular Biology Protein Expression and Purification Research, Shire
- Jo Nettleship, Senior Scientist, Protein Purification, OPPF-UK
- Frank Schaefer, Associate Director R&D/Head of DNA & Protein Sciences, Qiagen
- Michael Sundstrom, Managing Director, University of Copenhagen Faculty of Health Sciences, NNF Centre for Protein Research
- Trevor Wilkinson, Associate Director, Protein Sciences, Lead Generation, Department of Antibody Discovery and Protein Engineering, Medimmune
- Bernhard Helk, Section Head, Novartis Pharma AG
- Jit Ray, Deputy Director, Sanofi Pasteur
- Young-Hwa Song, Staff scientist, EMBL
- Thomas Jostock, Fellow/Technology Platform Leader, Novartis Pharma AG
- Melvyn Little, Chief Scientific Officer, Affimed Therapeutics AG
- Judith Hartleib, Team Leader, Astrazeneca
- Pim Hermans, Head of Ligand Discovery, BAC
- Thomas Purkarthofer, VTU Technology GmbH
- Robert Mabry, Group Leader, Adimab
- Nicole Schneiderhan, Project Leader Biochemistry, University of Tuebingen
- Arne Skerra, Professor, TU München, CEO & Founder Pieris AG
- Imre Berger, Group Leader, EMBL
